Monoclonal antibody therapeutics with up to five specificities: functional enhancement through fusion of target-specific peptides.
LaFleur DW, Abramyan D, Kanakaraj P, Smith RG, Shah RR, Wang G, Yao XT, Kankanala S, Boyd E, Zaritskaya L, Nam V, Puffer BA, Buasen P, Kaithamana S, Burnette AF, Krishnamurthy R, Patel D, Roschke VV, Kiener PA, Hilbert DM, Barbas CF 3rd.
LaFleur DW, et al. Among authors: yao xt.
MAbs. 2013 Mar-Apr;5(2):208-18. doi: 10.4161/mabs.23043.
MAbs. 2013.
PMID: 23575268
Free PMC article.